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Abstract 
Drug manufacturing is an extremely regulated industry, where regulatory agencies established actions to assure high quality of 
pharmaceuticals. Testing final products in laboratory requires adequate facilities and equipment. Error occurrence in 
measurement of drug physicochemical properties introduces risk in quality of products, which could be harmful for patients. 
Errors are frequently produced by use of inadequately calibrated instruments. This derived in a need of establishing methods and 
frequency of calibration. Due to the ambiguity of regulations and continuous technological advances, regulations are not well 
defined. European and USA Pharmacopoeias are main sources of information for analytical testing, thus, should describe 
requirements for calibration. Several EP and USP methods require calibration or verification of instruments, but in most cases 
these operations are not well defined. FDA states that equipment should be calibrated following specific procedures, with defined 
limits and intervals according to written programs. Because regulations provide inadequate guidance for laboratories, 
independent organizations release guidelines to promote best practices. Integration of guidelines and standards in regulatory 
documents would improve calibration procedures and diminish risk of errors. 
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1. Introduction  
The process of drug manufacturing is an extremely regulated industry, where several regulatory agencies around 
the globe have established several actions to control, maintain and assure higher degree of quality of 
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pharmaceuticals. Testing samples of final products in the Quality Control Laboratory requires adequate facilities and 
qualified and adequately calibrated or verified equipment and instruments. Error occurrence in the correct 
measurement of physicochemical properties of drug substances introduces a risk in the quality of these products, 
which can be harmful for the patients. Measurement errors are frequently produced by the use of inadequately 
calibrated instruments of equipment. This derived in a need of establishing valid methods and frequency of 
equipment calibration. But due to the ambiguity of current regulations and the continuous technological advances, 
regulations are incomplete and/or not well defined. 
Because regulations provide inadequate guidance for modern laboratories, independent organizations release 
standards and guidelines to improve industry operations and promote best practices. So, several calibration 
regulations appeared from ISO, ASTM, AOAC and other institutions that help industry to improve their standard 
operating procedures. 
The aim of this study is to show the needs to establish, describe and unify defined methods for calibration and or 
verification (metrological confirmation) of main instruments and equipment used in pharmaceutical laboratories to 
check quality of drugs in the different Pharmacopoeias and regulation agencies. 
2. Methodology and Discussion 
According to ISO 9000, on fundamentals and vocabulary on quality Management systems, Quality control is the 
part of quality management focused on fulfilling quality requirements. Analytical quality control, commonly 
shortened to AQC, refers to all those processes and procedures designed to ensure that the quality requirements of 
the products being analysed are of the highest level of confidence, which means that results of laboratory analysis 
are consistent, comparable, accurate, and within specified limits of precision. Quality control Samples submitted to 
the analytical laboratory must be accurately described to avoid faulty interpretations, approximations or incorrect 
results. The qualitative and quantitative data generated from the laboratory can then be used for decision making. In 
a chemical sense, quantitative analysis refers to the measurement of the amount or concentration of an element or 
chemical compound that differs from other elements or compounds. Several fields such as industry, medicine or law 
enforcement can make use of AQC. In a few words, quality control means the measure of precision, or how well the 
measurement system reproduces the same result over time and under varying operating conditions. Quality control 
begins with sample collection and ends with the reporting of data. AQC is achieved through laboratory control of 
analytical performance. Initial control of the complete system can be achieved through specification of laboratory 
services, instrumentation, glassware, reagents, solvents and gases. However, evaluation of daily performance must 
be documented to ensure continual production of valid data. A check should first be done to ensure that the data 
should be seen is precise and accurate. This, applied to equipment, usually constitutes the initial calibration and/or 
adjustment of the measuring instrument. Next, systematic daily checks such as analysing blanks, standards, quality 
control check samples, and references must be performed to establish the reproducibility of the data. These checks 
help to certify that the methodology is measuring what is in the sample. These checks are also verifications, and, 
with initial and/or periodic calibration and adjustment, constitute the metrological confirmation, that is well 
described in ISO 10012 standard. 
But measuring instruments tend to change in its response in output or set point value over long periods of time 
due to such factors as temperature, voltage, and time. This effect is called drift, and is the main reason of the needs 
of periodic recalibration and adjustment of instruments. 
At present, European and United States Pharmacopoeias (EP [1] / USP [2]) are the main source of information 
for analytical testing in a Pharmaceutical Quality Control laboratory, thus, should describe main requirements for 
calibration of equipment. In fact, there are several monographs in both pharmacopoeias that stablish periodic 
calibration or, at least, a verification of equipment used for the described analysis, but in most cases, there´s not a 
description on how to develop these activities, or limits for accuracy and precision are not well described.  
Several EP and USP methods require calibration and/or verification of instruments, but in most cases there´s not 
a clear difference between these two concepts, methods are not described and limits for these operations are not well 
defined. There are as many definitions of calibration as there are methods. According to the International 
Vocabulary of Metrology (VIM) [3], calibration is defined as an operation that, under specified conditions, in a first 
step, establishes a relation between the quantity values with measurement uncertainties provided by measurement 
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standards and corresponding indications with associated measurement uncertainties and, in a second step, uses this 
information to establish a relation for obtaining a measurement result from an indication. According to The 
Automation, Systems, and Instrumentation Dictionary (ISA), the word calibration is defined as “a test during which 
known values of measurand are applied to the transducer and corresponding output readings are recorded under 
specified conditions.” The definition includes the capability to adjust the instrument to zero and to set the desired 
span. An interpretation of the definition would say that a calibration is a comparison of measuring equipment against 
a standard instrument of higher accuracy to detect, correlate, adjust, rectify and document the accuracy of the 
instrument being compared. Typically, calibration of an instrument gives its metrological characteristics, is checked 
at several points throughout the calibration range of the instrument. The calibration range is defined as “the region 
between the limits within which a quantity is measured, received or transmitted, expressed by stating the lower and 
upper range values.” The limits are defined by the zero and span values. The zero value is the lower end of the 
range. Span is defined as the algebraic difference between the upper and lower range values. The calibration range 
may differ from the instrument range, which refers to the capability of the instrument. Calibration finishes with the 
emission of a calibration certificate. 
The concept of verification is different than a calibration: VIM and ISA define verification as a confirmation by 
examination and provision of objective evidence that a given item fulfils specified requirements. Verification 
includes several activities of confirmation, for example that performance properties or legal requirements of a 
measuring system are achieved, or that a given reference material is homogeneous for a quantity value and a 
measurement procedure concerned, or that a target measurement uncertainty can be met. In some cases, where the 
specified requirements are adequate for an intended use, the verification is called validation. While calibration 
indicates the error of the instrument and compensates for any lack of trueness by applying a correction, verification 
indicates that the measurement error is smaller than a so called maximum permissible error. Users define the 
maximum permissible error as the largest error that they are prepared to accept. 
These two concepts are included in a unique concept, called Metrological confirmation, which comprises a set of 
operations required to ensure that measuring equipment conforms to the requirements for its intended use. 
Metrological confirmation generally includes calibration and verification, any necessary adjustment or repair, and 
subsequent recalibration, comparison with the metrological requirements for the intended use of the equipment, as 
well as any required sealing and labelling. In all these process, it is very important to know the acceptance limits or 
requirements. 
Because pharmaceutical industries are governed by the Good Manufacturing Practices (GMPs), instrumentation 
must remain in a validated state, and the site calibration program is a critical part of this effort. GMPs in Europe, and 
current GMPs (cGMPs) in the United States, are the practices required in order to conform to guidelines 
recommended by agencies that control authorization and licensing for manufacture and sale of food, drug products 
and active pharmaceutical products. These guidelines provide minimum requirements that a pharmaceutical or a 
food product manufacturer must meet to assure that the products are of the highest quality and do not suppose any 
risk to the consumer or public. cGMPs are enforced by the U.S. FDA in a Code of Federal Regulations, 21CFR Parts 
210 and 211 [4], where they establish several requirements for equipment and measuring instruments. Specifically, 
21 CFR 211 states that “automatic, mechanical, or electronic equipment or other types of equipment, including 
computers, or related systems that will perform a function satisfactorily, may be used in the manufacture, 
processing, packing, and holding of a drug product. Concretely, FDA, in Subpart D of 21 CFR 211, Code of Federal 
Regulations, in its section 211.68 states that equipment used to manufacture drugs should “be routinely calibrated, 
inspected or checked.” Section 211.160 of Subpart I emphasizes laboratory controls and requires calibration of all 
instruments “at suitable intervals in accordance with an established written program”, and “Calibration procedures 
shall include specific directions and limits for accuracy and precision, and provisions for remedial action in the 
event accuracy and/or precision limits are not met. Instruments, apparatus, gauges, and recording devices not 
meeting established specifications shall not be used.” It is left up to individual laboratories to define and defend their 
choices for calibration, limits and corrective actions.  
In the same way, in the hole world by the International Council of Harmonization (ICH) on Good Manufacturing 
Practice Guide for Active Pharmaceutical Ingredients (through the compliance policy guide Q7A [5]) and in Europe 
by the European Commission (through the Annex 15 to the EU Guide to Good Manufacturing Practice [6-7]) state 
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that “Control, weighing, measuring, monitoring and test equipment that is critical for assuring the quality of 
intermediates or APIs should be calibrated according to written procedures and an established schedule”, but neither 
particular procedures of calibration, verification or metrological confirmation nor acceptance criteria are defined. 
The European Directorate for the Quality of Medicines and Healthcare (EDQM) is responsible for the Secretariat 
of the European Pharmacopoeia Commission and for preparing the General Chapters and Monographs of the 
European Pharmacopoeia with the groups of experts. The Official Medicines Control Laboratories (OMCL) is a 
network of laboratories belonging to the Council of Europe that develop and upgrade several guidelines of 
calibration and/or qualification of laboratory measuring instruments and equipment. These guidelines are not 
mandatory, but can be used by quality control laboratories to establish calibration methods and frequencies. Several 
calibration/qualification methods are developed, for example, for calibration of balances [8], pipettes [9]. In the 
United States of America, another association called the American Society for Testing Materials (ASTM) developed 
also similar calibration guidelines for instruments and reference materials. 
All these regulations are not only compatible but also completed with standards from International Organization 
for Standardization (ISO), an organization that developed general standards for managing measurement systems, 
including processes and measuring systems, such as ISO 10012, managing quality systems such as ISO 9001, 
general requirements for the competence of testing and calibration laboratories such as ISO 17025, and also specific 
standards such as UNE EN ISO 45501 on Metrological aspects of non-automatic weighing instruments or ISO 4787 
for calibration of volumetric instruments of laboratory glassware. 
Table 1. Calibration Regulations and Guidelines for an analytical balance 
Test USP FEU ISO OMCL 
Cal Freq. ND ND ND ND 
Linearity Yes No Yes Yes 
Sensitivity Yes No Yes No 
Accuracy* Yes No Yes Yes 
Precision Yes No Yes Yes 
Eccentricity Yes No Yes Yes 
Drift No No No Yes 
Minimum weight Yes No No Yes 
Measurement 
uncertainty 
No No Yes Yes 
* Note that in the International Vocabulary for Metrology and in documents of 
the ISO, the term Accuracy is referred to as trueness. 
An example of some of these regulations and guidelines applied to a laboratory weighing balance is shown in 
Table 1. 
3. Conclusions 
As it is described in the present article, calibration of measuring instruments and laboratory equipment is 
essential for controlling and maintaining the highest quality of pharmaceuticals, because laboratory results are 
critical for the safety of patients. The article shows the needs of establishing adequate calibration procedures for 
these instruments and equipment in order to demonstrate the quality and trueness of measurements given by the 
laboratory. 
Many pharmaceutical companies are not sure about how to calibrate their laboratory equipment, which tests 
apply in each case or which the best frequency of calibration is. In this study, several international documents about 
pharmaceutical industry and its regulation about Metrology have been analysed, showing that in most cases, 
Pharmacopoeias don´t define well how to calibrate, while regulatory agencies such as FDA or European agencies 
are requiring in their regulations all these aspects. 
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The detailed explanation in this paper gives a clear idea of the needs of establishing common calibration 
procedures for basic laboratory equipment, showing some differences between mandatory documents and 
guidelines. The Integration of guidelines and standards of private and public organizations in unique regulatory 
documents such as Pharmacopoeias would lead to improve and unify equipment calibration procedures, facilitating 
inspections and diminishing risk of measuring errors, which ultimately, leads to improvement in quality of 
pharmaceuticals. 
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